Clinical Guides
Generalised Anxiety Disorder
An India-adapted clinical guide to recognising pervasive uncontrollable worry, excluding urgent mimics, and arranging stepped, evidence-based care for adults with generalised anxiety disorder.
MedNext Academy | 13 min read
Generalised Anxiety Disorder
An India-adapted clinical guide to recognising pervasive uncontrollable worry, excluding urgent mimics, and arranging stepped, evidence-based care for adults with generalised anxiety disorder.
Summary
Generalised anxiety disorder (GAD) is characterised by excessive anxiety and worry about several areas of life, difficulty controlling that worry, associated physical or cognitive symptoms, persistence, distress and impaired function. The worry is not confined to one trigger such as social scrutiny, contamination, trauma reminders or an unexpected panic attack. Patients may instead present with poor sleep, muscle tension, fatigue, headache, palpitations, gastrointestinal discomfort, repeated reassurance seeking or frequent attendance for changing physical symptoms. Diagnosis is clinical and should follow a sufficiently broad medical, psychiatric, medication and substance assessment. A questionnaire can support recognition and measurement but cannot establish GAD by itself.
Care begins with a shared explanation that validates symptoms without prematurely attributing every physical complaint to anxiety. Assess self-harm, severe depression, mania, psychosis, intoxication, withdrawal, domestic violence and acute medical illness at the first encounter. For non-emergency GAD, current guidelines describes stepped care: education and active monitoring, low-intensity psychological interventions, then high-intensity cognitive behavioural therapy, applied relaxation or appropriately prescribed medication according to severity, response and preference. Complex refractory illness needs specialist input. Treatment goals should include ordinary function, sleep, avoidance, participation and quality of life rather than a questionnaire score alone. This India-adapted educational draft does not provide an individual diagnosis or medication regimen and has been reviewed by the MedNext Clinical Team. [GAD-1]
How Common Is It?
GAD is a commonly encountered anxiety disorder, but a single prevalence number should not be transferred uncritically between countries or clinical settings. Estimates change with the diagnostic classification used, required duration, age range, sampling method, interview quality and whether functional impairment is mandatory. People seen in primary care may report bodily distress, insomnia or repeated worry without using a mental-health label; specialist samples over-represent severe and treatment-resistant illness. An international estimate therefore cannot be presented as an India-wide rate without a directly comparable, representative Indian survey.
The clinical burden is broader than case count. Persistent worry may erode concentration, examination performance, parenting, relationships, work attendance, financial decision-making and management of chronic disease. Repeated tests and consultations can occur when neither patient nor clinician has a coherent formulation, while genuine physical illness can be missed if symptoms are dismissed as anxiety. Onset and course vary: symptoms can be longstanding, episodic or intensified by illness, bereavement, debt, caregiving, pregnancy, workplace insecurity or other stressors. These events may contribute but do not automatically prove GAD. In India, stigma, language, distance, cost, limited access to structured psychotherapy and reliance on family support influence when and how people seek care. WHO mhGAP supports care for mental disorders in non-specialist settings, but local capacity and referral routes must be confirmed rather than assumed. [GAD-2]
Risk Factors
GAD does not have one necessary or sufficient cause. Family vulnerability, temperament marked by behavioural inhibition or high threat sensitivity, adverse experiences, chronic stress, physical illness and learned patterns of avoidance or reassurance can interact. A risk factor describes probability, not destiny, weakness or blame. The clinician should ask about the timing of symptoms relative to bereavement, violence, migration, financial strain, caregiving, examinations, workplace conflict, pregnancy, menopause, chronic pain and new diagnoses. A detailed account often reveals both predisposing vulnerability and maintaining factors that can be addressed.
Depression, other anxiety disorders, obsessive-compulsive disorder, post-traumatic stress symptoms, alcohol or drug use and medically unexplained symptoms commonly complicate presentation. Caffeine, nicotine, stimulants, decongestants, corticosteroids, thyroid medicines and withdrawal from alcohol, benzodiazepines or other sedatives can worsen anxiety-like symptoms. Hyperthyroidism, arrhythmia, anaemia, hypoglycaemia, asthma, sleep apnoea and pain can produce overlapping complaints and need clinically directed assessment. Poor sleep, avoidance, repeated internet searching, repeated checking of bodily sensations and family reassurance may reduce distress briefly while maintaining long-term worry. Ask privately about coercion and violence; apparent anxiety may be an understandable response to current danger. Protective factors include safe relationships, stable routines, treatment access, physical activity suited to health status and the ability to discuss distress without shame. None of these replaces a risk assessment when function deteriorates. [GAD-1]
Diagnosis
History
Clarify the main worries, how many life domains they involve, controllability, duration, associated restlessness, fatigue, concentration difficulty, irritability, muscle tension and sleep disturbance, and the effect on study, work, relationships and self-care. Ask what the patient fears will happen, what they do to obtain certainty, and whether avoidance or reassurance brings only temporary relief. Establish prior episodes, treatment, family history, medicines, caffeine, nicotine, alcohol and other substances. Screen directly for depression, self-harm, mania, psychosis, trauma, obsessive symptoms, panic and current safety.
Examination
Observe distress, psychomotor state, speech, thought form, mood, affect, insight and cognition. Record relevant observations and conduct a focused physical examination guided by symptoms, for example cardiovascular, respiratory, neurological or thyroid findings. Assess hydration, nutrition, injuries and capacity where an urgent treatment decision is required.
Investigations
No blood test or scan diagnoses GAD. Order tests only to answer a clinical question raised by history or examination, such as thyroid dysfunction, anaemia, pregnancy, arrhythmia, metabolic disturbance or substance effect. Current guidelines suggests GAD-2 for identification and GAD-7 for assessment or monitoring, but a score must be interpreted with clinical context. Diagnosis requires persistent excessive worry across domains, difficulty controlling it, associated symptoms, distress or impairment, and exclusion of a better explanation. [GAD-1]
Differential Diagnosis
Ordinary worry is proportionate, often linked to a defined problem and usually settles when the problem resolves; GAD is pervasive, difficult to control and functionally impairing. Panic disorder centres on recurrent unexpected panic attacks and concern about further attacks, although background worry may coexist. Social anxiety disorder is organised around scrutiny, embarrassment or rejection. Obsessive-compulsive disorder involves intrusive obsessions and compulsive responses, while post-traumatic stress disorder links symptoms to trauma exposure and reminders. Illness anxiety focuses predominantly on feared disease, and adjustment disorder is temporally linked to an identifiable stressor without automatically meeting criteria for another disorder.
Depressive disorders may include rumination, early waking, hopelessness and loss of interest; bipolar disorder requires enquiry about episodes of elevated or irritable mood, increased activity and reduced need for sleep. Psychosis can include fixed false beliefs or hallucinations rather than recognised, excessive worry. Autism, attention-deficit hyperactivity disorder and learning disability can alter communication, sensory load and uncertainty. Hyperthyroidism, arrhythmia, anaemia, hypoglycaemia, vestibular disease, asthma, menopause symptoms, pain, sleep disorders and medication or substance effects can mimic or amplify anxiety. Akathisia may be mistaken for restlessness. Delirium, intoxication and withdrawal are acute medical presentations. The safest formulation can include more than one diagnosis; identifying GAD must not erase a concurrent physical disorder, current violence or substance-related risk. [GAD-1]
Management
Start with collaborative explanation, immediate risk management and agreement on the problems that matter most to the patient. Explain that worry, arousal, avoidance, reassurance and sleep disruption can reinforce one another, while making clear that symptoms are real. current guidelines stepped care begins with identification, education and active monitoring. If symptoms persist, low-intensity options include evidence-based self-help, guided self-help or psychoeducational groups delivered to an appropriate standard. Marked impairment or inadequate response supports a choice between high-intensity cognitive behavioural therapy, applied relaxation or pharmacological treatment, informed by preference, prior response, comorbidity, pregnancy potential, access and risk.
CBT for GAD should be delivered by a competent practitioner using a treatment manual and supervision; it is more than generic reassurance. Work may address intolerance of uncertainty, unhelpful beliefs about worry, avoidance, behavioural experiments, attention and relapse planning. Applied relaxation requires structured training rather than an instruction simply to relax. Encourage sleep regularity, reduced harmful alcohol or stimulant use and physical activity appropriate to the person, but do not present lifestyle advice as a substitute for treatment. Agree measurable goals such as returning to classes, reducing repeated reassurance calls or completing essential tasks. Review symptoms, function, adherence, adverse effects and safety. Treat important comorbidity in a planned sequence and ensure that waiting-list delays do not leave a high-risk patient without follow-up. [GAD-1]
Prescribing Information
Medication for GAD should follow a confirmed clinical assessment and shared decision with an appropriately qualified prescriber. Current guidelines includes selective serotonin reuptake inhibitors within drug treatment for adults and advises discussion of benefits, adverse effects, interactions, withdrawal phenomena, delayed onset and the possibility of early activation. Choice in India must also reflect current approved indications, national or institutional formulary, comorbidity, pregnancy or breastfeeding, age, overdose risk, previous response and affordability. This guide intentionally supplies no product selection, dose, titration or taper schedule. A patient should not start, share, escalate or abruptly stop a medicine using this page.
Early follow-up is important when symptoms are severe, suicidal thoughts are present, activation occurs or adherence is uncertain. Review sleep, agitation, gastrointestinal symptoms, sexual adverse effects, bleeding risk, hyponatraemia risk where relevant, interactions and emerging mania. Benzodiazepines should not become routine long-term treatment for GAD; Current guidelines reserves them for short-term use during crises because tolerance, dependence, withdrawal, falls, impaired driving and dangerous interaction with alcohol, opioids or other sedatives can occur. Antipsychotics are not routine primary-care treatment for GAD. Herbal or over-the-counter products can interact with prescribed medicines and should be disclosed. If dependence or withdrawal is possible, arrange a clinician-led plan rather than sudden cessation. In pregnancy, breastfeeding, frailty, liver or kidney disease, or complex polypharmacy, seek condition-appropriate specialist advice. [GAD-1]
When to Refer
Arrange emergency assessment for active suicidal intent, a recent serious attempt, severe self-neglect, inability to maintain safety, psychosis, mania, delirium, severe intoxication or withdrawal, violent risk, or an acute medical presentation. Refer urgently when anxiety accompanies chest pain, syncope, severe breathlessness, new neurological deficit, seizure, marked metabolic disturbance or another symptom requiring time-sensitive medical care. Do not direct a medically unstable patient solely to counselling. Safeguarding or domestic-violence pathways may be necessary when worry reflects ongoing coercion or danger.
Refer to psychiatry or an appropriately skilled mental-health service for diagnostic uncertainty, very marked impairment, significant suicide risk, complex comorbidity, pregnancy-related complexity, substance dependence, treatment resistance or need for a complex drug and psychological plan. current guidelines step 4 describes specialist care for complex refractory GAD and very marked functional impairment. A person needing structured CBT may be referred earlier according to local service design; referral is not evidence of failure. In India, routes may include a Health and Wellness Centre, primary health centre, district mental-health service, medical-college psychiatry unit, private specialist or emergency department. Confirm availability and cost rather than promising a service. Handover should state worries and function, risks, physical findings, substance and medicine history, previous care, patient preference, language or access needs and a safe contact method. [GAD-3]
Red Flags
Immediate red flags include suicidal intent or planning, a recent attempt, escalating self-harm, threats to others, command hallucinations, severe agitation, mania, psychosis, delirium, inability to eat or drink, profound self-neglect, severe intoxication or withdrawal, and inability to care safely for dependants. Clinical anxiety must not be used to explain away chest pain, syncope, cyanosis, severe breathlessness, seizure, altered consciousness, focal neurological deficit, fever with confusion, severe hypoglycaemia or another acute physiological abnormality. Arrange emergency medical care and supervised transfer according to local protocol.
Rapid deterioration after starting or changing a psychiatric medicine, new reduced need for sleep with increased energy, marked impulsivity or severe inner restlessness requires prompt reassessment. Repeated early requests for sedatives, mixing tablets with alcohol, or abrupt discontinuation may signal dependence or withdrawal. Ask privately about violence, coercion, stalking, financial control and whether family contact is safe. A calm presentation does not exclude high risk, and a high questionnaire score does not by itself define an emergency. Document the patient’s words, intent, access to means, protective factors, capacity considerations, physical findings, people contacted and agreed transfer or safety plan. Do not leave an acutely unsafe person alone or send them away with only a relaxation handout. [GAD-3]
Indian Clinical Context
GAD care in India must work across varied languages, literacy, family structures, costs and availability of psychotherapy. The Ministry of Health and Family Welfare operational guidance for mental, neurological and substance-use care supports identification, basic psychosocial care, referral and follow-up within primary-care systems. It does not guarantee that every facility has a therapist trained in GAD-specific CBT, nor does it replace a verified district pathway. Explain the formulation in the patient’s preferred language, use a qualified interpreter where possible, and obtain consent before involving relatives. Family support can help with attendance and recovery, but repeated reassurance or coercive control may also maintain symptoms or create danger.
The Mental Healthcare Act, 2017 provides a rights-based framework relevant to access, dignity, confidentiality, capacity and emergency treatment. Anxiety or disagreement alone does not establish incapacity. Section 115 addresses attempted suicide through a presumption of severe stress and a duty to provide care, treatment and rehabilitation; clinicians must still perform and document an individual risk assessment. international and WHO recommendations are useful evidence comparators but are not Indian licensing, formulary, legal or service rules. Verify the current local medicine information, referral destination and emergency number. Financial debt, examination pressure, migration, caste or gender discrimination and unsafe work may be genuine drivers of distress; care should address social realities without reducing a persistent disorder to advice to think positively. [GAD-3]
NMC Competency Mapping
Within NMC CBME 2024, GAD supports integrated learning across psychiatry, medicine, pharmacology, community medicine, emergency care, communication and professionalism. At Know level, learners should describe pervasive excessive worry, associated symptoms, impairment and common differential diagnoses. At Know How level, they should explain why a screening score is not a diagnosis, how medicines and physical illness can mimic anxiety, and how stepped care links severity and response to intervention. They should distinguish ordinary worry, GAD, panic, social anxiety, OCD, trauma-related illness, depression, mania and substance withdrawal in a clinical vignette.
At Show How level, a learner should take a respectful anxiety, substance and medication history; perform a focused mental-state and physical assessment; ask directly about suicide; explain uncertainty; and give a concise handover. Simulated assessment should reward validation without premature reassurance, clinically directed investigations and safe escalation. At Perform level, any patient care remains supervised and within local scope. Learners must not prescribe, change or withdraw psychiatric medicines independently because they have read a guide. Professional competencies include confidentiality, consent, decision-specific capacity, safe family involvement, documentation and recognition of structural barriers to care. This mapping is educational and does not claim that reading one guide completes an NMC competency or authorises unsupervised practice. [GAD-4]
Key Exam Pearls for NEET PG
GAD involves excessive, difficult-to-control worry across several domains with associated symptoms and functional impairment; worry confined to scrutiny, contamination, trauma reminders or recurrent unexpected panic suggests another primary formulation. GAD-2 and GAD-7 are aids to identification or monitoring, not stand-alone diagnostic tests. There is no routine laboratory test for GAD: investigate a specific alternative raised by the history or examination. Hyperthyroidism, arrhythmia, hypoglycaemia, substances, withdrawal, depression and mania are high-yield mimics or comorbidities. Reduced need for sleep with increased energy points away from simple anxiety and toward mania.
Current guidelines uses a stepped-care model: education and active monitoring, low-intensity psychological intervention, then high-intensity CBT, applied relaxation or medication for greater impairment or inadequate response, with specialist care for complex refractory illness. CBT is a structured treatment, not generic reassurance. Long-term routine benzodiazepine use is a poor answer because of dependence, withdrawal and safety risks. In an emergency vignette, suicidality, psychosis, delirium, intoxication, withdrawal or acute medical red flags take priority over a questionnaire or relaxation advice. The best management answer combines risk assessment, patient preference, treatment of relevant comorbidity, functional goals and review. International guidance must be adapted to Indian formulary, legal and service context. [GAD-1]
Frequently Asked Questions
How is generalised anxiety disorder different from ordinary worry about real problems?
Ordinary worry is usually proportionate to a specific difficulty, can be set aside for periods of time and tends to reduce when the problem is resolved. GAD involves persistent, excessive worry across several areas, difficulty controlling it, associated tension or cognitive symptoms and meaningful distress or impairment. The distinction is clinical, not a moral judgement and not simply a count of stressful events. A clinician should also ask whether current violence, debt, illness or unsafe work creates a real threat that needs practical action. Questionnaires can organise symptoms but cannot decide this distinction alone. New chest symptoms, severe breathlessness, suicidal intent, mania, confusion or withdrawal require urgent assessment rather than a label of ordinary worry or GAD.
Can a GAD-7 score confirm the diagnosis or determine treatment by itself?
No. GAD-7 can help measure symptom burden and change, while GAD-2 can support initial identification, but neither replaces a diagnostic history, functional assessment, mental-state examination, physical review and risk assessment. A high score may occur with depression, panic, trauma, substance withdrawal or acute stress, and a low score may miss symptoms because of language, shame or misunderstanding. Treatment decisions should consider duration, impairment, patient preference, medical conditions, medicines, substances, previous response and safety. Repeat measurement can be useful when the same tool and context are used, but improvement should also mean better sleep, participation, self-care or work rather than only a lower number.
Are sedative tablets a safe long-term solution for persistent generalised anxiety?
They are not a routine long-term solution. Benzodiazepines can cause tolerance, dependence, withdrawal, impaired driving, falls and dangerous interactions with alcohol, opioids or other sedatives. Current guidelines reserves them for short-term use during crises rather than ordinary continuing treatment of GAD. Anyone already using a sedative regularly should not stop abruptly from information on a webpage; withdrawal can be serious and needs clinician-led assessment. Evidence-based psychological treatment or an appropriately prescribed longer-term medicine may be considered after diagnosis and shared decision-making. Seek urgent help for overdose, severe drowsiness, breathing difficulty, confusion, seizure, escalating use or withdrawal symptoms.
When should anxiety symptoms be treated as an emergency rather than a routine appointment?
Use emergency care for active suicidal intent, a recent serious attempt, danger to others, psychosis, mania, delirium, severe intoxication or withdrawal, inability to maintain food or fluids, or profound self-neglect. Chest pain, syncope, severe breathlessness, seizure, altered consciousness, focal neurological deficit or another acute physiological abnormality also needs urgent medical assessment; anxiety must not be assumed to be the cause. Do not leave an acutely unsafe person alone or ask them to drive themselves. Tell the receiving team about medicines, alcohol or drug use, physical symptoms, self-harm risk, dependants and whether family contact is safe. A routine anxiety questionnaire should never delay stabilisation or supervised transfer.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic